Literature DB >> 24734864

Effectiveness of active self-care complementary and integrative medicine therapies: options for the management of chronic pain symptoms.

Cindy Crawford1, Courtney Lee, Daniel Freilich.   

Abstract

OBJECTIVES: Chronic pain management typically consists of prescription medications or provider-based, behavioral, or interventional procedures that are often ineffective, may be costly, and can be associated with undesirable side effects. Because chronic pain affects the whole person (body, mind, and spirit), patient-centered complementary and integrative medicine (CIM) therapies that acknowledge the patients' roles in their own healing processes have the potential to provide more efficient and comprehensive chronic pain management. Active self-care CIM (ACT-CIM) therapies allow for a more diverse, patient-centered treatment of complex symptoms, promote self-management, and are relatively safe and cost-effective. To date, there are no systematic reviews examining the full range of ACT-CIM used for chronic pain symptom management.
METHODS: A systematic review was conducted, using Samueli Institute's Rapid Evidence Assessment of the Literature methodology, to rigorously assess both the quality of the research on ACT-CIM modalities and the evidence for their efficacy and effectiveness in treating chronic pain symptoms. A working group of subject matter experts was also convened to evaluate the overall literature pool and develop recommendations for the use and implementation of these modalities.
RESULTS: Following key database searches, 146 randomized controlled trials were included in the review, 18 of which directly compared ACT-CIM approaches with one another.
CONCLUSIONS: This article summarizes the current evidence, quality, effectiveness, and safety of these modalities. Recommendations and next steps to move this field of research forward are also discussed. The entire scope of the review is detailed throughout the current Pain Medicine supplement. Wiley Periodicals, Inc.

Entities:  

Keywords:  Chronic Pain; Comparative Effectiveness Research; Complementary and Integrative Medicine; Rapid Evidence Assessment of the Literature; Self-Care; Systematic Review

Mesh:

Year:  2014        PMID: 24734864     DOI: 10.1111/pme.12407

Source DB:  PubMed          Journal:  Pain Med        ISSN: 1526-2375            Impact factor:   3.750


  5 in total

1.  Treatment of Low Back Pain With Opioids and Nonpharmacologic Treatment Modalities for Army Veterans.

Authors:  Megan E Vanneman; Mary Jo Larson; Cheng Chen; Rachel Sayko Adams; Thomas V Williams; Esther Meerwijk; Alex H S Harris
Journal:  Med Care       Date:  2018-10       Impact factor: 2.983

2.  Postdeployment Polytrauma Diagnoses Among Soldiers and Veterans Using the Veterans Health Affairs Polytrauma System of Care and Receipt of Opioids, Nonpharmacologic, and Mental Health Treatments.

Authors:  Rachel Sayko Adams; Mary Jo Larson; Esther L Meerwijk; Thomas V Williams; Alex H S Harris
Journal:  J Head Trauma Rehabil       Date:  2019 May/Jun       Impact factor: 2.710

3.  Assessing the Relative Effectiveness of Combining Self-Care with Practitioner-Delivered Complementary and Integrative Health Therapies to Improve Pain in a Pragmatic Trial.

Authors:  Steven B Zeliadt; Scott Coggeshall; Hannah Gelman; Marlena H Shin; A Rani Elwy; Barbara G Bokhour; Stephanie L Taylor
Journal:  Pain Med       Date:  2020-12-12       Impact factor: 3.637

Review 4.  Quality of conduct and reporting in rapid reviews: an exploration of compliance with PRISMA and AMSTAR guidelines.

Authors:  Shannon E Kelly; David Moher; Tammy J Clifford
Journal:  Syst Rev       Date:  2016-05-10

5.  Patterns of conventional and complementary non-pharmacological health practice use by US military veterans: a cross-sectional latent class analysis.

Authors:  Melvin T Donaldson; Melissa A Polusny; Rich F MacLehose; Elizabeth S Goldsmith; Emily M Hagel Campbell; Lynsey R Miron; Paul D Thuras; Erin E Krebs
Journal:  BMC Complement Altern Med       Date:  2018-09-05       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.